AR
Advisory Research Portfolio holdings
AUM
$651M
1-Year Return
25.02%
This Quarter Return
-24.41%
1 Year Return
+25.02%
3 Year Return
+143.09%
5 Year Return
+422.22%
10 Year Return
+498.78%
AUM
$1.44B
AUM Growth
-$733M
(-34%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-12.9%
Top 10 Holdings %
Top 10 Hldgs %
26.07%
Holding
366
New
63
Increased
73
Reduced
132
Closed
88
Top Buys
| 1 |
Microsoft
MSFT
|
$40.7M |
| 2 |
Hershey
HSY
|
$26M |
| 3 |
Valvoline
VVV
|
$22.6M |
| 4 |
Avnet
AVT
|
$20.3M |
| 5 |
Zurn Elkay Water Solutions
ZWS
|
$18.9M |
Top Sells
| 1 |
Lamar Advertising Co
LAMR
|
$39.2M |
| 2 |
Huntington Bancshares
HBAN
|
$34.7M |
| 3 |
Acushnet Holdings
GOLF
|
$29.8M |
| 4 |
Jack in the Box
JACK
|
$29M |
| 5 |
Verizon
VZ
|
$26.1M |
Sector Composition
| 1 | Consumer Discretionary | 17.82% |
| 2 | Financials | 17.59% |
| 3 | Technology | 12.58% |
| 4 | Industrials | 11.47% |
| 5 | Healthcare | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
PennyMac Financial
PFSI
$6.08B
| $774K | 0.05% |
34,998
-2,114
| -6% | -$46.8K |
|
152
Iridium Communications
IRDM
$2.67B
| $763K | 0.05% |
+34,191
| New | +$763K |
|
|
XLRN
153
DELISTED
Acceleron Pharma Inc.
XLRN
| $751K | 0.05% |
+8,359
| New | +$751K |
|
154
Strategic Education
STRA
$1.95B
| $750K | 0.05% |
5,363
-7,381
| -58% | -$1.03M |
|
155
Moderna
MRNA
$9.8B
| $748K | 0.05% |
24,965
-13,957
| -36% | -$418K |
|
156
Vanguard Mid-Cap ETF
VO
$87B
| $725K | 0.05% |
+5,505
| New | +$725K |
|
157
Arvinas
ARVN
$592M
| $717K | 0.05% |
17,798
-13,204
| -43% | -$532K |
|
|
ENV
158
DELISTED
ENVESTNET, INC.
ENV
| $714K | 0.05% |
+13,280
| New | +$714K |
|
159
Domino's
DPZ
$15.6B
| $704K | 0.05% |
2,171
+1,018
| +88% | +$330K |
|
|
DCPH
160
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $697K | 0.05% |
16,918
+7,481
| +79% | +$308K |
|
161
AudioCodes
AUDC
$273M
| $694K | 0.05% |
29,051
-395
| -1% | -$9.44K |
|
162
Kodiak Sciences
KOD
$535M
| $693K | 0.05% |
14,525
-4,511
| -24% | -$215K |
|
|
INOV
163
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $689K | 0.05% |
41,348
+9,455
| +30% | +$158K |
|
164
Axalta
AXTA
$6.88B
| $664K | 0.05% |
38,470
-7,450
| -16% | -$129K |
|
165
Natera
NTRA
$23.2B
| $662K | 0.05% |
22,183
-13,462
| -38% | -$402K |
|
166
Twist Bioscience
TWST
$1.54B
| $658K | 0.05% |
+21,525
| New | +$658K |
|
167
Palomar
PLMR
$3.28B
| $646K | 0.04% |
+11,099
| New | +$646K |
|
|
HZNP
168
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $642K | 0.04% |
21,658
-23,105
| -52% | -$685K |
|
169
InMode
INMD
$944M
| $626K | 0.04% |
58,248
+35,194
| +153% | +$378K |
|
170
Tesla
TSLA
$1.13T
| $604K | 0.04% |
17,280
-13,965
| -45% | -$488K |
|
|
EQC.PRD
171
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
| $599K | 0.04% |
23,000
| – | – |
|
|
TPTX
172
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $594K | 0.04% |
13,294
-6,477
| -33% | -$289K |
|
173
RingCentral
RNG
$2.85B
| $584K | 0.04% |
2,758
+712
| +35% | +$151K |
|
174
Y-mAbs Therapeutics
YMAB
$390M
| $584K | 0.04% |
22,391
-11,560
| -34% | -$302K |
|
175
CoStar Group
CSGP
$37.8B
| $577K | 0.04% |
9,820
-5,140
| -34% | -$302K |
|